Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q3 2024 Oncology Update

Skip to the end of the Expertise Menu

Q3 2024 Oncology Update

Transaction activity in oncology practice management has maintained its rapid pace, with 10 closed transactions in Q3 2024, bringing the year-to-date total to 24.

Investor interest remains robust, with consolidators such as OneOncology and The US Oncology Network closing five and four transactions, respectively. A notable transaction includes OneOncology’s acquisition of United Urology Group from Audax Group, further strengthening OneOncology’s position within the cancer care ecosystem. Additionally, Cardinal Health’s acquisition of Integrated Oncology Network from private equity firm Silver Oak Services Partners marks a significant milestone. Now, each of the three largest pharmaceutical wholesalers has ownership stakes in community oncology practices, signaling their commitment to vertical integration and managing drug spending in oncology therapeutics.

With the launch of a new platform, Provident anticipates intensified competition for add-on acquisitions. For groups that may not meet platform criteria, the growing pool of buyers presents an opportunity to explore additional partnership options.

To print and download the full Oncology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/10/Q3-2024-Oncology-Newsletter_vP.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]